DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 5.278
EU - Europa 2.410
AS - Asia 915
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
OC - Oceania 4
Totale 8.643
Nazione #
US - Stati Uniti d'America 5.191
IT - Italia 558
DE - Germania 492
CN - Cina 357
SE - Svezia 344
IE - Irlanda 280
SG - Singapore 265
RU - Federazione Russa 189
GB - Regno Unito 158
UA - Ucraina 152
HK - Hong Kong 107
CA - Canada 82
VN - Vietnam 64
FI - Finlandia 62
FR - Francia 47
IN - India 43
BE - Belgio 31
DK - Danimarca 30
AT - Austria 29
TR - Turchia 27
JP - Giappone 14
CL - Cile 13
IR - Iran 12
NL - Olanda 10
ID - Indonesia 9
ES - Italia 7
EU - Europa 7
BR - Brasile 5
GE - Georgia 5
IQ - Iraq 5
DO - Repubblica Dominicana 4
PT - Portogallo 4
RO - Romania 4
AU - Australia 3
NG - Nigeria 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
MU - Mauritius 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
Totale 8.643
Città #
Ann Arbor 1.487
Chandler 410
Fairfield 392
Woodbridge 392
Frankfurt am Main 363
Wilmington 337
Dublin 271
Ashburn 262
Houston 254
Singapore 231
Milan 194
Jacksonville 174
Dearborn 160
Seattle 149
New York 137
Cambridge 132
Princeton 113
Hong Kong 105
Nanjing 78
Shanghai 61
Santa Clara 60
Lawrence 47
Altamura 38
Dong Ket 37
Lachine 30
Beijing 29
Helsinki 28
Vienna 28
Boardman 26
Brussels 24
Andover 22
Grafing 21
Ottawa 21
San Diego 20
Nanchang 19
Pune 19
Fremont 18
Jinan 18
Monza 18
Guangzhou 17
Rome 17
Shenyang 15
Zhengzhou 15
Kocaeli 14
Los Angeles 14
Santiago 13
Toronto 13
Falls Church 12
Tianjin 12
Hebei 11
London 11
Changsha 10
Hangzhou 10
Lissone 10
Moscow 10
Edmonton 9
Jakarta 9
Leawood 9
Monmouth Junction 9
Jiaxing 8
Mountain View 8
Bari 7
Dallas 7
Detroit 7
Kunming 7
Turin 7
Chicago 6
Segrate 6
Taizhou 6
Auburn Hills 5
Brugherio 5
Dalmine 5
Hefei 5
Munich 5
Ningbo 5
University Park 5
Bologna 4
Brooklyn 4
Lappeenranta 4
Leipzig 4
Norwalk 4
Peschiera Borromeo 4
Rho 4
Samaná 4
Sesto San Giovanni 4
Southwark 4
Squillace 4
Stockholm 4
São Paulo 4
Tokyo 4
Truyes 4
Verona 4
Abuja 3
Alpharetta 3
Bergamo 3
Bonndorf 3
Borgo Val di Taro 3
Bournemouth 3
Brescia 3
Casarile 3
Totale 6.657
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 367
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 330
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 308
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 277
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 273
Effect of the ketogenic diet in excitable tissues 242
Generation and validation of algorithms to identify subjects with dementia using administrative data 241
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 236
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 220
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 201
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 190
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 187
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 186
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 185
Cardiac and neuronal HCN channelopathies 184
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 183
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 180
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 180
Brain targets: can you believe your own eyes? 171
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 170
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 166
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 164
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 159
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 159
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 158
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 156
Cerebral amyloid angiopathy-related inflammation: an emerging disease 154
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 152
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 150
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 149
HCN1 novel mutations in familiar generalized epilepsy 147
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 145
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 144
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 142
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 139
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 138
Epilptic seizures and psychogenic non-epileptic seizures 135
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 125
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 124
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 123
Complicanze neurologiche di malattie internistiche 121
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 119
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 118
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 116
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 106
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 104
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 101
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 88
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 85
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 83
Neurological soft signs are increased in migraine without aura: relationship with the affective status 77
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 66
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 66
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 64
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 61
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 61
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 57
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 50
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 50
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 48
Cerebral Amyloid Angiopathy-Related Inflammation 46
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 42
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 20
Totale 9.189
Categoria #
all - tutte 29.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.182 0 0 0 114 131 187 222 105 149 121 117 36
2020/20211.643 75 88 181 161 121 140 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/2025594 135 283 156 20 0 0 0 0 0 0 0 0
Totale 9.189